Date: 1 November 2024
Reason for Follow-up:
Patient reports continued improvement in headache frequency and severity since starting new prophylactic medication. Reports only 2 mild headaches in the past month, lasting less than an hour each, compared to daily severe headaches previously. No associated aura, photophobia, or phonophobia. Denies any new concerns.
Repeat Clinical Review:
Blood pressure 128/82 mmHg (previously 135/88 mmHg). Heart rate 72 bpm, regular. Respiratory rate 16 breaths/min. Temperature 36.8°C. Neurological examination remains unremarkable, no focal deficits noted. Patient appears well and alert. No tenderness on palpation of paranasal sinuses or neck muscles.
Repeat Biochemistry Review:
Full Blood Count: Within normal limits. Liver Function Tests: ALT 25 U/L (ref range <40), AST 20 U/L (ref range <35), ALP 70 U/L (ref range 30-130). Renal Function Tests: Urea 4.5 mmol/L (ref range 2.5-7.8), Creatinine 78 µmol/L (ref range 60-110). All values are stable and within normal ranges, showing no adverse effects from new medication. Previous LFTs were also normal.
Repeat Imaging:
Repeat MRI brain not indicated at this stage given positive clinical response and stability of symptoms. Initial MRI brain from 3 months ago showed no abnormalities.
Plan:
Continue current prophylactic medication (Propranolol 40mg BID). Advised to continue headache diary. Reassessed need for further imaging, decided against at present. Will review in 3 months time or sooner if symptoms worsen or new concerns arise. Patient encouraged to maintain adequate hydration and sleep. Provided information leaflet on headache management.
Date: [Insert date of consultation] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)
Reason for Follow-up:
[Describe current symptoms, progress since last consultation, new concerns, or specific issues requiring follow-up] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)
Repeat Clinical Review:
[Detail findings from repeat clinical examination, including vital signs, physical examination findings, and comparison with previous examinations] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)
Repeat Biochemistry Review:
[Summarise results of repeat biochemical tests, including specific values, reference ranges if stated, and interpretation relative to prior results] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)
Repeat Imaging:
[Report findings from repeat imaging studies, including imaging modality, key observations, and comparison with prior imaging] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)
Plan:
[Outline ongoing management including medication changes, investigations ordered, referrals made, follow-up arrangements, and patient advice] (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)
(For each section, only include information if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit the section entirely. Never include direct quotations. Never come up with your own patient details, assessments, interpretations, plans, interventions, or follow-up actions—use only the transcript, contextual notes or clinical note as the source of truth. If any information related to a placeholder has not been explicitly mentioned, do not state that it is missing; simply omit the placeholder or section entirely.)